MedPath
NMPA Approval

Dolutegravir Sodium Dispersible Tablets

国药准字HJ20230060

May 29, 2023

Drug Information

多替拉韦钠分散片

片剂

5mg(以多替拉韦计)

化学药品

May 29, 2023

May 28, 2028

Company Information

Applicant Company

ViiV Healthcare BV

Van Asch van Wijckstraat 55H, 3811 LP Amersfoort, Netherlands

Manufacturing Company

glaxo operations uk ltd (trading as glaxo wellcome operations)

Priory Street Hertfordshire SG12 0DJ Ware UK

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

多替拉韦钠分散片 - NMPA 批准文号 | MedPath